Regulatory watch

Where do new medicines originate from in the EU?

Article metrics

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Origin of new medicines in the European Union (2010–2012).

Author information

Correspondence to Constantinos Ziogas.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information S1 (box)

Details of data and analysis (PDF 255 kb)

Supplementary information S2 (Table)

Origin of orphan and non-orphan new medicines in the EU: 2010–2012 (PDF 202 kb)

PowerPoint slides

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Lincker, H., Ziogas, C., Carr, M. et al. Where do new medicines originate from in the EU?. Nat Rev Drug Discov 13, 92–93 (2014) doi:10.1038/nrd4232

Download citation

Further reading